Automated PCR detection of BRAF mutations in colorectal adenocarcinoma: a diagnostic test accuracy study

被引:22
作者
Colling, Richard [1 ]
Wang, Lai Mun [1 ]
Soilleux, Elizabeth [1 ,2 ]
机构
[1] Oxford Univ Hosp NHS Trust, Dept Cellular Pathol, Oxford, England
[2] Univ Oxford, Nuffield Div Clin Lab Sci, Oxford, England
关键词
LYNCH SYNDROME; CANCER;
D O I
10.1136/jclinpath-2015-203345
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background Testing for BRAF mutations in colorectal carcinoma (CRC) is important in the screening pathway for Lynch syndrome and is of prognostic value to guide management. This is a diagnostic accuracy study of the Idylla system, a novel and automated alternative PCR system. Methods 100 consecutive formalin-fixed, paraffin-embedded CRC resection cases were tested for BRAF mutations using the Idylla automated platform and compared with standard (Cobas) PCR. Results The sensitivity of the Idylla BRAF test was 100% and the specificity was 96%. Only one discordant Idylla positive/standard PCR negative result occurred and on Droplet Digital PCR demonstrated a mutation not identified by traditional PCR in this case. Conclusion This study has validated the Idylla system for BRAF testing in CRC and demonstrated a possibly greater sensitivity, in addition to cost effectiveness and shorter turnaround time, when compared with standard PCR.
引用
收藏
页码:398 / 402
页数:5
相关论文
共 21 条
  • [1] [Anonymous], 2014, STANDARDS DATASETS R
  • [2] [Anonymous], NCCN CLIN PRACTICE G
  • [3] Bio-Rad Laboratories, QX200 DROPL DIG PCR
  • [4] Simple nomograms to calculate sample size in diagnostic studies
    Carley, S
    Dosman, S
    Jones, SR
    Harrison, M
    [J]. EMERGENCY MEDICINE JOURNAL, 2005, 22 (03) : 180 - 181
  • [5] Screening for Lynch syndrome and referral to clinical genetics by selective mismatch repair protein immunohistochemistry testing: an audit and cost analysis
    Colling, Richard
    Church, David N.
    Carmichael, Juliet
    Murphy, Lucinda
    East, James
    Risby, Peter
    Kerr, Rachel
    Chetty, Runjan
    Wang, Lai Mun
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (12) : 1036 - 1039
  • [6] BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer
    Deng, GR
    Bell, I
    Crawley, S
    Gum, J
    Terdiman, JP
    Allen, BA
    Truta, B
    Sleisenger, MH
    Kim, YS
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (01) : 191 - 195
  • [7] Devogelaere B, 2013, CANC RES S, V73, P4213
  • [8] Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis
    Gallego, Carlos J.
    Shirts, Brian H.
    Bennette, Caroline S.
    Guzauskas, Greg
    Amendola, Laura M.
    Horike-Pyne, Martha
    Hisama, Fuki M.
    Pritchard, Colin C.
    Grady, William M.
    Burke, Wylie
    Jarvik, Gail P.
    Veenstra, David L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (18) : 2084 - U145
  • [9] Guidelines on genetic evaluation and management of Lynch syndrome: A consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer
    Giardiello, Francis M.
    Allen, John I.
    Axilbund, Jennifer E.
    Boland, C. Richard
    Burke, Carol A.
    Burt, Randall W.
    Church, James M.
    Dominitz, Jason A.
    Johnson, David A.
    Kaltenbach, Tonya
    Levin, Theodore R.
    Lieberman, David A.
    Robertson, Douglas J.
    Syngal, Sapna
    Rex, Douglas K.
    [J]. GASTROINTESTINAL ENDOSCOPY, 2014, 80 (02) : 197 - 220
  • [10] Molecular Alterations and Biomarkers in Colorectal Cancer
    Grady, William M.
    Pritchard, Colin C.
    [J]. TOXICOLOGIC PATHOLOGY, 2014, 42 (01) : 124 - 139